Previewing AACR 2024 With Select Pre-Meeting Highlights

by Bernice Lottering
Share To
Source: AACR

American Association for Cancer Research, 2024 Annual Meeting

The AACR Annual Meeting 2024 is scheduled to take place at the San Diego Convention Center in California, running from April 5th to April 10th. Taking place every year, the AACR Annual Meeting serves as the central hub for the cancer research community, bringing together scientists, clinicians, healthcare professionals, survivors, patients, and advocates to exchange the most recent breakthroughs in cancer science and medicine. This year’s rich program spans the breadth of oncology, encompassing advancements in population science, prevention, cancer biology, translational and clinical studies, as well as survivorship and advocacy. It showcases the innovative work of leading researchers and medical professionals from institutions across the globe.

GeneOnline will conduct a special report on the AACR. The following table is a preview of some of the exciting content to be shared.

2024 AACR Select Research Highlights by Oscar Wu, GeneOnline

With approximately 22 000 attendees, 630 speakers and 450 exhibitors, present throughout the 6 day conference, the AACR Annual meeting promises to be a rich source of information within the oncology field. Featuring educational conferences, specialized courses, workshop lectures, special forums and educational materials, this ground-breaking comprehensive content is something not to be missed.

Reference: AACR Official Website

© All rights reserved. Collaborate with us:
Related Post
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
Oncology’s New Drugs on the Horizon (I): Cancer Immunotherapy and Targeted Therapy
Connecting Biotech Ecosystems: Success of Los Angeles Event Sets Stage for APAC-US Collaboration
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top